Prognostic Value of Basic Fibroblast Growth Factor and Its Receptor (FGFR-1) in Patients with Non-small Cell Lung Carcinomas

By Volm M.   Koomagi R.   Mattern J.   Stammler G.  

European Journal of Cancer, Vol. 33, Iss. 4, 1997-04 ,pp. : 691-693

Elsevier

Access to resources Recommend Favorite

Downregulation of NOB1 suppresses the proliferation and tumor growth of non-small cell lung cancer in vitro and in vivo

By            

Oncology Reports, Vol. 31, Iss. 3, 2014-01 ,pp. : 1271-1276

Spandidos Publications

Access to resources Recommend Favorite

Allelic imbalance at loci containing FGFR, FGF, c-Met and HGF candidate genes in non-small cell lung cancer sub-types, implication for progression

By Beau-Faller M.   Gaub M.P.   Schneider A.   Guerin E.   Meyer N.   Ducrocq X.   Massard G.   Gasser B.   Kessler R.   Weitzenblum E.   Wihlm J.M.   Quoix E.   Oudet P.  

European Journal of Cancer, Vol. 39, Iss. 17, 2003-11 ,pp. : 2538-2547

Elsevier

Access to resources Recommend Favorite

A novel imidazopyridine PI3K inhibitor with anticancer activity in non-small cell lung cancer cells

By              

Oncology Reports, Vol. 30, Iss. 2, 2013-01 ,pp. : 863-869

Spandidos Publications

Access to resources Recommend Favorite

Norcantharidin suppresses cell growth and migration with enhanced anticancer activity of gefitinib and cisplatin in human non-small cell lung cancer cells

By                        

Oncology Reports, Vol. 29, Iss. 1, 2013-01 ,pp. : 237-243

Spandidos Publications

Access to resources Recommend Favorite